指南与共识重症综合管理与镇静镇痛消化、代谢与肾脏急症

复杂胃肠镜的深度镇静与麻醉:英国胃肠病学会、联合咨询组与皇家麻醉医师学院联合立场声明

Deep sedation and anaesthesia in complex gastrointestinal endoscopy: a joint position statement endorsed by the British Society of Gastroenterology (BSG), Joint Advisory Group (JAG) and Royal College of Anaesthetists (RCoA).
指南 / 共识 · Frontline Gastroenterol · 2019-01-09
一句话结论英国多学会联合声明:复杂或长时间胃肠镜操作中,由麻醉医师主导的丙泊酚深度镇静可改善患者舒适度与操作成功率,但具体镇静剂选择由麻醉医师决定。

英国每年开展超过250万例内镜操作,多数由内镜医师使用苯二氮䓬类和阿片类药物行清醒镇静。在长时间复杂操作(如内镜逆行胰胆管造影)中,该镇静方式可能镇静不足或过度,影响操作成功率和患者结局,且高剂量苯二氮䓬类和阿片类药物存在安全隐患。随着诊断和治疗性内镜技术快速发展,本联合立场声明概述英国镇静使用现状,强调麻醉医师主导的深度镇静(以丙泊酚为主)的作用,并涵盖深度镇静与麻醉的适应证、患者选择与评估、操作细节、设备环境人员配置与监测要求、急诊与择期内镜的考虑以及培训、审计和未来发展方向。

要点

  • 英国每年开展超过250万例内镜操作,多数由内镜医师使用苯二氮䓬类和阿片类药物行清醒镇静。
  • 长时间复杂操作(如内镜逆行胰胆管造影)中,清醒镇静可能镇静不足或过度,影响操作成功率和患者结局,且高剂量苯二氮䓬类和阿片类药物存在安全隐患。
  • 声明强调麻醉医师主导的深度镇静(以丙泊酚为主)的作用,但镇静或麻醉药物的最终选择由麻醉医师决定。
  • 声明涵盖深度镇静与麻醉的适应证、患者选择与评估、操作细节、设备环境人员配置与监测要求。
  • 声明详述急诊与择期不同内镜操作的考虑,并讨论培训、审计、依从性和未来发展。

适用人群与场景

  • 接受长时间、复杂胃肠镜操作的患者,如内镜逆行胰胆管造影。
  • 声明同时考虑急诊与择期内镜操作场景。

处置流程与药物剂量

  • 深度镇静与麻醉由麻醉医师主导,以丙泊酚镇静为重点,但镇静或麻醉药物的最终选择由麻醉医师决定。
  • 声明涵盖深度镇静与麻醉的适应证、患者选择与评估、操作细节、设备环境人员配置与监测要求。

研究设计与关键结果

  • 英国每年开展超过250万例内镜操作,多数由内镜医师使用苯二氮䓬类和阿片类药物行清醒镇静。
  • 在长时间复杂操作中,该镇静方式可能镇静不足或过度,对操作成功率和患者结局产生负面影响,且高剂量苯二氮䓬类和阿片类药物存在安全隐患。

证据类型、等级与局限

  • 证据类型:英国胃肠病学会(BSG)、联合咨询组(JAG)与皇家麻醉医师学院(RCoA)联合立场声明。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 声明强调在长时间复杂胃肠镜操作中麻醉医师主导的深度镇静(以丙泊酚为主)的作用,但药物最终选择由麻醉医师决定。
  • 声明提出需关注深度镇静与麻醉的设备、环境、人员配置与监测要求,以及培训、审计和依从性。

指南或共识出处

  • Deep sedation and anaesthesia in complex gastrointestinal endoscopy: a joint position statement endorsed by the British Society of Gastroenterology (BSG), Joint Advisory Group (JAG) and Royal College of Anaesthetists (RCoA),发表于 Frontline Gastroenterol。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

In the UK, more than 2.5 million endoscopic procedures are carried out each year. Most are performed under conscious sedation with benzodiazepines and opioids administered by the endoscopist. However, in prolonged and complex procedures, this form of sedation may provide inadequate patient comfort or result in oversedation. As a result, this may have a negative impact on procedural success and patient outcome. In addition, there have been safety concerns on the high doses of benzodiazepines and opioids used particularly in prolonged and complex procedures such as endoscopic retrograde cholangiopancreatography. Diagnostic and therapeutic endoscopy has evolved rapidly over the past 5 years with advances in technical skills and equipment allowing interventions and procedural capabilities that are moving closer to minimally invasive endoscopic surgery. It is vital that safe and appropriate sedation practices follow the inevitable expansion of this portfolio to accommodate safe and high-quality clinical outcomes. This position statement outlines the current use of sedation in the UK and highlights the role for anaesthetist-led deep sedation practice with a focus on propofol sedation although the choice of sedative or anaesthetic agent is ultimately the choice of the anaesthetist. It outlines the indication for deep sedation and anaesthesia, patient selection and assessment and procedural details. It considers the setup for a deep sedation and anaesthesia list, including the equipment required, the environment, staffing and monitoring requirements. Considerations for different endoscopic procedures in both emergency and elective setting are also detailed. The role for training, audit, compliance and future developments are discussed.

来源:Frontline Gastroenterol,查看原文。版权归原作者所有。

参考来源

  1. Sidhu R, Turnbull D, Newton M, et al. Deep sedation and anaesthesia in complex gastrointestinal endoscopy: a joint position statement endorsed by the British Society of Gastroenterology (BSG), Joint Advisory Group (JAG) and Royal College of Anaesthetists (RCoA). Frontline Gastroenterol. 2019. PMID: 31205654. doi:10.1136/flgastro-2018-101145

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。